Cambridge Investment Research Advisors, Inc. Merck & Co., Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 450,791 shares of MRK stock, worth $41.6 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
450,791
Previous 464,199
2.89%
Holding current value
$41.6 Million
Previous $52.7 Million
14.93%
% of portfolio
0.15%
Previous 0.18%
Shares
32 transactions
Others Institutions Holding MRK
# of Institutions
3,965Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.2 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.2 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.45 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.64 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $234B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...